A detailed history of Koss Olinger Consulting, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 2,925 shares of MRK stock, worth $290,891. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,925
Previous 2,863 2.17%
Holding current value
$290,891
Previous $354,000 6.21%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$111.15 - $128.97 $6,891 - $7,996
62 Added 2.17%
2,925 $332,000
Q2 2024

Aug 06, 2024

BUY
$123.8 - $132.96 $354,439 - $380,664
2,863 New
2,863 $354,000
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $146,763 - $159,714
-1,465 Reduced 22.12%
5,157 $562,000
Q3 2023

Oct 10, 2023

SELL
$102.95 - $114.33 $18,016 - $20,007
-175 Reduced 2.57%
6,622 $681,000
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $10,911 - $12,175
-106 Reduced 1.54%
6,797 $723,000
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $946,363 - $1.21 Million
-10,823 Reduced 61.06%
6,903 $765,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $194,841 - $218,882
-2,305 Reduced 11.51%
17,726 $1.53 Million
Q2 2022

Jul 08, 2022

SELL
$83.49 - $94.64 $231,183 - $262,058
-2,769 Reduced 12.14%
20,031 $1.83 Million
Q1 2022

May 06, 2022

BUY
$73.51 - $82.4 $9,923 - $11,124
135 Added 0.6%
22,800 $1.87 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $298,227 - $373,568
-4,126 Reduced 15.4%
22,665 $1.74 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $57,917 - $63,694
808 Added 3.11%
26,791 $2.01 Million
Q2 2021

Aug 11, 2021

BUY
$70.31 - $77.77 $120,933 - $133,764
1,720 Added 7.09%
25,983 $2.02 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $1.67 Million - $1.97 Million
24,263 New
24,263 $1.87 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.